Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogueVladimir Tolmachev, Irina Velikyan, Mattias Sandström, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2009
Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotateMattias Sandström, Ulrike Garske, Dan Granberg, et al.International Journal of Molecular Medicine|February 3, 2007
Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligandThuy Tran, Anna Orlova, Igor Sivaev, et al.Nuclear Medicine and Biology|December 6, 2011
Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibodyJennie Malmberg, Mattias Sandström, Kenneth Wester, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATEEzgi Ilan, Irina Velikyan, Mattias Sandström, et al.Physics in Medicine and Biology|February 24, 2005
Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECTMattias Sandström, Vladimir Tolmachev, Kalevi Kairemo, et al.EJNMMI Physics|December 9, 2020
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time pointsMattias Sandström, Nanette Freedman, Katarzyna Fröss-Baron, et al.EJNMMI Research|May 19, 2023
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expressionUlrika Jahn, Ulrike Garske-Román, Mattias Sandström, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2010
Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levelsVladimir Tolmachev, Helena Wållberg, Mattias Sandström, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2016
Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image ContrastEzgi Ilan, Mattias Sandström, Irina Velikyan, et al.Pageof 8